SCHEMBL26645404

SCHEMBL26645404

CC(C)(C)OC(=O)N1Cc2c(I)c(Br)nn2C(C)(C)C1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.40
▸ RORC P51449 2/20 0.34
▸ USP2 O75604 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ GPR119 Q8TDV5 2/20 0.32
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ ESR2 Q92731 1/20 0.30
▸ F2RL1 P55085 1/20 0.30
▸ JAK1 P23458 1/20 0.30
▸ DDB1 Q16531 1/20 0.30
▸ CRBN Q96SW2 1/20 0.30
▸ BUB1 O43683 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645539 0.79 GPR119 (0.39) NR1H2RORCHDAC1GPR119F2RL1
SCHEMBL26645305 0.78 F2RL1 (0.42) NR1H2RORCHDAC1MEN1KMT2A
SCHEMBL26645063 0.76 NR1H2 (0.38) NR1H2USP2SMN1; SMN2MEN1KMT2A
SCHEMBL26645111 0.76 NR1H2 (0.33) NR1H2RORCBUB1
SCHEMBL30622794 0.74 NR1H2 (0.35) NR1H2RORCUSP2SMN1; SMN2GPR119
SCHEMBL26645573 0.74 NR1H2 (0.44) NR1H2RORCHDAC1GPR119ESR2
SCHEMBL30622818 0.66 SETD7 (0.34) NR1H2HDAC1GPR119MEN1KMT2A
SCHEMBL26645349 0.66 SETD7 (0.34) NR1H2HDAC1GPR119MEN1KMT2A
SCHEMBL30622784 0.66 SETD7 (0.34) NR1H2HDAC1GPR119MEN1KMT2A
SCHEMBL16709107 0.65 NR1H2 (0.35) NR1H2GPR119JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback